Palivizumab prophylaxis of RSV infections in Bosnia and Herzegovina

• Main Authors: Suada Heljic (Author), Hajrija Maksic (Author), Hidajeta Begic (Author), Fahrija Skokic (Author), Darinka Glamuzina (Author), Tomica Bozic (Author), Stojislav Konjevic (Author), Veroslava Milosevic (Author), Sabina Terzic (Author)
• Format: Book
• Published: Hygeia Press di Corridori Marinella, 2016-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Palivizumab is indicated for respiratory syncytial virus (RSV) prophylaxis in high-risk children. Methods: Observational study, based on 4 sites in Bosnia and Herzegovina (B&H), with institutional reports of infants at high risk for RSV who received at least 1 dose of palivizumab dur...